Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HES Coload Volumes and Norepinephrine ED90 for Hypotension in C-Section
NCT05712018Completed
- Sponsor
- General Hospital of Ningxia Medical University
- Start
- Oct 2023
- Primary completion
- Jan 2024
- Modality
- Polymer-based Nanoparticles, Lipid-based Nanoparticles, Small Molecules
- Countries
- 1
01
Overview
Randomised trial of hetastarch in hypotension (3 arms), sponsored by General Hospital of Ningxia Medical University. Primary endpoint: 90% Effective Dose of Norepinephrine. Started Oct 2023; status: completed.
02
Drugs
hetastarch
03
Conditions
hypotension
Beyond the preview
Go deeper on NCT05712018.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05712018.